人工智能驱动的药物发现的双重用途。
Dual Use of Artificial Intelligence-powered Drug Discovery.
作者信息
Urbina Fabio, Lentzos Filippa, Invernizzi Cédric, Ekins Sean
机构信息
Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC 27606, USA.
Department of Global Health & Social Medicine, King's College London, United Kingdom.
出版信息
Nat Mach Intell. 2022 Mar;4(3):189-191. doi: 10.1038/s42256-022-00465-9. Epub 2022 Mar 7.
Abstract
An international security conference explored how artificial intelligence (AI) technologies for drug discovery could be misused for de novo design of biochemical weapons. A thought experiment evolved into a computational proof.
摘要
一次国际安全会议探讨了用于药物研发的人工智能（AI）技术如何可能被滥用于生化武器的从头设计。一个思想实验演变成了一个计算证明。
相似文献
1
Dual Use of Artificial Intelligence-powered Drug Discovery.人工智能驱动的药物发现的双重用途。
Nat Mach Intell. 2022 Mar;4(3):189-191. doi: 10.1038/s42256-022-00465-9. Epub 2022 Mar 7.
2
New avenues in artificial-intelligence-assisted drug discovery.人工智能辅助药物发现的新途径。
Drug Discov Today. 2023 Apr;28(4):103516. doi: 10.1016/j.drudis.2023.103516. Epub 2023 Feb 2.
3
Unleashing the power of generative AI in drug discovery.释放生成式人工智能在药物研发中的力量。
Drug Discov Today. 2024 Jun;29(6):103992. doi: 10.1016/j.drudis.2024.103992. Epub 2024 Apr 23.
4
Artificial Intelligence and Machine Learning in Pharmacological Research: Bridging the Gap Between Data and Drug Discovery.药理学研究中的人工智能与机器学习：弥合数据与药物发现之间的差距
Cureus. 2023 Aug 30;15(8):e44359. doi: 10.7759/cureus.44359. eCollection 2023 Aug.
5
Artificial intelligence in drug discovery: recent advances and future perspectives.药物研发中的人工智能：最新进展与未来展望。
Expert Opin Drug Discov. 2021 Sep;16(9):949-959. doi: 10.1080/17460441.2021.1909567. Epub 2021 Apr 2.
6
Piquing artificial intelligence towards drug discovery: Tools, techniques, and applications.激发人工智能在药物发现中的应用：工具、技术和应用。
Drug Dev Res. 2024 Apr;85(2):e22159. doi: 10.1002/ddr.22159.
7
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design.人工智能技术在新冠病毒从头设计药物中的应用。
Int J Mol Sci. 2022 Mar 17;23(6):3261. doi: 10.3390/ijms23063261.
8
Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.探索人工智能和机器学习模型在药物设计难题方面的应用及对制药行业未来的潜在影响。
Methods. 2023 Nov;219:82-94. doi: 10.1016/j.ymeth.2023.09.010. Epub 2023 Sep 29.
9
Artificial intelligence for drug discovery: Resources, methods, and applications.用于药物发现的人工智能：资源、方法及应用
Mol Ther Nucleic Acids. 2023 Feb 18;31:691-702. doi: 10.1016/j.omtn.2023.02.019. eCollection 2023 Mar 14.
10
Evolution of Artificial Intelligence-Powered Technologies in Biomedical Research and Healthcare.人工智能驱动技术在生物医学研究与医疗保健中的发展
Adv Biochem Eng Biotechnol. 2022;182:23-60. doi: 10.1007/10_2021_189.
引用本文的文献
1
Machine learning- and multilayer molecular network-assisted screening hunts fentanyl compounds.机器学习和多层分子网络辅助筛选寻找芬太尼化合物。
Sci Adv. 2025 Sep 5;11(36):eadw2799. doi: 10.1126/sciadv.adw2799.
2
The Blurred Lines Between New Psychoactive Substances and Potential Chemical Weapons.新型精神活性物质与潜在化学武器之间的模糊界限
Toxics. 2025 Aug 1;13(8):659. doi: 10.3390/toxics13080659.
3
Steering towards safe self-driving laboratories.转向安全的自动驾驶实验室。
Nat Rev Chem. 2025 Aug 18. doi: 10.1038/s41570-025-00747-x.
4
Awareness of the dual-use dilemma in scientific research: reflections and challenges to Latin America.对科学研究中两用困境的认识：对拉丁美洲的思考与挑战。
Front Bioeng Biotechnol. 2025 Jul 28;13:1649781. doi: 10.3389/fbioe.2025.1649781. eCollection 2025.
5
Dual-Use Research and Publication Policies: A Comparison of Journals in Life Sciences and Artificial Intelligence.两用研究与出版政策：生命科学与人工智能领域期刊的比较
Appl Biosaf. 2025 Jun 5;30(2):97-106. doi: 10.1089/apb.2024.0034. eCollection 2025 Jun.
6
Unmet Expectations: Life Scientists' Views on Biorisk and Responsibility.未满足的期望：生命科学家对生物风险与责任的看法
Appl Biosaf. 2025 Jun 5;30(2):112-123. doi: 10.1089/apb.2024.0052. eCollection 2025 Jun.
7
Emerging technologies transforming the future of global biosecurity.新兴技术正在改变全球生物安全的未来。
Front Digit Health. 2025 Jun 4;7:1622123. doi: 10.3389/fdgth.2025.1622123. eCollection 2025.
8
Cutting-edge AI tools revolutionizing scientific research in life sciences.前沿人工智能工具正在彻底改变生命科学领域的科学研究。
BioTechnologia (Pozn). 2025 Mar 31;106(1):77-102. doi: 10.5114/bta/200803. eCollection 2025.
9
Ethical Frameworks for Data-Driven Environmental Health Studies in the AI Era.人工智能时代数据驱动的环境卫生研究的伦理框架
Environ Health (Wash). 2025 Feb 6;3(5):443-445. doi: 10.1021/envhealth.4c00273. eCollection 2025 May 16.
10
A framework for evaluating the chemical knowledge and reasoning abilities of large language models against the expertise of chemists.一个根据化学家的专业知识来评估大语言模型化学知识和推理能力的框架。
Nat Chem. 2025 May 20. doi: 10.1038/s41557-025-01815-x.
本文引用的文献
1
MegaSyn: Integrating Generative Molecular Design, Automated Analog Designer, and Synthetic Viability Prediction.MegaSyn：整合生成性分子设计、自动化类似物设计和合成可行性预测
ACS Omega. 2022 May 27;7(22):18699-18713. doi: 10.1021/acsomega.2c01404. eCollection 2022 Jun 7.
2
Erratum: CATMoS: Collaborative Acute Toxicity Modeling Suite.勘误：CATMoS：协作急性毒性建模套件。
Environ Health Perspect. 2021 Jul;129(7):79001. doi: 10.1289/EHP9883. Epub 2021 Jul 9.
3
AiZynthFinder: a fast, robust and flexible open-source software for retrosynthetic planning.人工智能合成路线搜索工具（AiZynthFinder）：一款用于逆合成规划的快速、强大且灵活的开源软件。
J Cheminform. 2020 Nov 17;12(1):70. doi: 10.1186/s13321-020-00472-1.
4
REINVENT 2.0: An AI Tool for De Novo Drug Design.REINVENT 2.0：一种用于从头设计药物的人工智能工具。
J Chem Inf Model. 2020 Dec 28;60(12):5918-5922. doi: 10.1021/acs.jcim.0c00915. Epub 2020 Oct 29.
5
Acetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: History, mechanisms of action, and medical countermeasures.乙酰胆碱酯酶抑制剂（神经毒剂）作为大规模杀伤性武器：历史、作用机制和医疗对策。
Neuropharmacology. 2020 Dec 15;181:108298. doi: 10.1016/j.neuropharm.2020.108298. Epub 2020 Sep 6.
6
The ToxCast program for prioritizing toxicity testing of environmental chemicals.用于对环境化学品毒性测试进行优先级排序的ToxCast计划。
Toxicol Sci. 2007 Jan;95(1):5-12. doi: 10.1093/toxsci/kfl103. Epub 2006 Sep 8.
Zotero 插件